CRMA and neoplasm: Regarding FasL, indirect evidence using tumour cells expressing inhibitors of the death receptor pathway like CrmA (a cowpox protein) or FLIP, suggested that FasL was also involved in NK cell-mediated tumour immunosurveillance (89, 90).